Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and a major cause of cancer mortality. Chemotherapy resistance remains a major challenge for treating advanced CRC. Therefore, the identification of targets that induce drug resistance is a priority for the development of novel ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ying, Huang, Xiao-Xiao, Chen, Guo-Bin, Wang, Ying, Zhi, Qiang, Liu, Yuan-Sheng, Wu, Xiao-Ling, Wang, Li-Fen, Yang, Bing, Xiao, Chuan-Xing, Xing, Hui-Qin, Ren, Jian-Lin, Xia, Yin, Guleng, Bayasi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216997/
https://www.ncbi.nlm.nih.gov/pubmed/27384995
http://dx.doi.org/10.18632/oncotarget.10338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216997/
https://www.ncbi.nlm.nih.gov/pubmed/27384995
http://dx.doi.org/10.18632/oncotarget.10338

Ejemplares similares